A protein called actin may signal a more aggressive glioma
Original title: Actin, connexin-43 and GAP-43 expression in gliomas: real-world associations with IDH status, tumor burden and survival.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was a look back at tumor samples and records from people, not a test of any treatment.
The short version
In tumor samples from people with glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary, more of a protein called actin went along with faster tumor growth and shorter survival.
What was studied. Researchers looked at tumor tissue from 134 adults who had surgery for a newly diagnosed glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary, WHO grades 2 to 4. They measured three proteins in the tissue: actin, Cx43, and GAP-43. Then they compared those levels to how the patients did over time.
What they found. Tumors with more actin tended to be higher grade and to have the IDH-wildtype form, which is the harder type. In those patients, the tumor started growing again sooner, 7.2 months compared to 17.4 months. They also lived a shorter time, 17.1 months compared to 81.5 months. In IDH-wildtype tumors, more of the protein Cx43 went along with living longer.
What this means, and what it doesn't
What it could mean: This may help doctors read more from a tumor sample one day. If these proteins hold up in more studies, they could give a clearer picture of how a tumor is likely to behave. Right now this is information about the tumor, not a new treatment.
What it doesn't mean: This does not mean there is a new drug or a new therapy. Nothing here was given to patients to treat their tumor. This was a look back at tissue and records from one center, so it shows a pattern, not a cause. Doctors do not test for these proteins as part of normal care. It is not a promise of a cure.
Source: PubMed, August 8, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.